Eargo announces closing of rights offering and conversion of patient square notes into shares of eargo common stock

San jose, calif., nov. 29, 2022 (globe newswire) -- eargo, inc. (“eargo” or the “company”) (nasdaq: ear), a medical device company on a mission to improve the quality of life for people with hearing loss, announced today the closing and final results of its rights offering, which expired at 5:00 p.m. new york city time, on november 17, 2022.
EAR Ratings Summary
EAR Quant Ranking